Metformin and Diabetic Kidney Disease: A Mini-Review on Recent Findings
| Author | Hamid Nasri | en |
| Author | Mahmoud Rafieian-Kopaei | en |
| Issued Date | 2014-10-31 | en |
| Abstract | Metformin, an oral anti-diabetic agent in the biguanide class is a widely prescribed drug to treat high blood glucose in patients with type 2 diabetes mellitus. Metformin has three different roles, including blood glucose regulatory effect, protection of kidney tubular cell by acting as an effective antioxidant and finally ameliorative effect on diabetic kidney disease through saving the podocytes. Therefore, diabetic patients may benefit from all of these three distinct ameliorative effects. | en |
| DOI | https://doi.org/ | en |
| Keyword | Metformin | en |
| Keyword | Kidney Disease | en |
| Keyword | Diabetes | en |
| Keyword | Anti-diabetic Agents | en |
| Publisher | Brieflands | en |
| Title | Metformin and Diabetic Kidney Disease: A Mini-Review on Recent Findings | en |
| Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IJPD-24-565.pdf
- Size:
- 184.91 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF